Search Results - "Burgermeister, E"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells by Yuan, G, Regel, I, Lian, F, Friedrich, T, Hitkova, I, Hofheinz, R D, Ströbel, P, Langer, R, Keller, G, Röcken, C, Zimmermann, W, Schmid, R M, Ebert, M P A, Burgermeister, E

    Published in Oncogene (17-01-2013)
    “…Resistance to chemotherapy is a major obstacle for curative treatment of human gastric cancer (GC). However, the underlying molecular mechanisms are largely…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Peroxisome proliferator-activated receptor-γ upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells by BURGERMEISTER, Elke, TENCER, Lilach, LISCOVITCH, Mordechai

    Published in Oncogene (19-06-2003)
    “…Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a nuclear receptor for eicosanoids that promotes differentiation of human epithelial and…”
    Get full text
    Journal Article
  4. 4

    Comparative Analysis of Docking Motifs in MAP-Kinases and Nuclear Receptors by Burgermeister, Elke, Lanzendoerfer, Martin, Scheuer, Werner

    “…Nuclear receptor (NR) agonists induce activation of mitogen-activated protein kinases (MAPK) through an yet unknown rapid non-genomic mechanism. Vice versa, NR…”
    Get full text
    Journal Article
  5. 5

    Activation of nuclear factor-kappaB by lipopolysaccharide in mononuclear leukocytes is prevented by inhibitors of cytosolic phospholipase A2 by Burgermeister, E, Tibes, U, Stockinger, H, Scheuer, W V

    Published in European journal of pharmacology (26-03-1999)
    “…In monocytes, lipopolysaccharide induces synthesis and activity of the 85-kDa cytosolic phospholipase A2. This enzyme releases arachidonic acid and…”
    Get full text
    Journal Article
  6. 6

    Inhibition of cytosolic phospholipase A(2) attenuates activation of mitogen-activated protein kinases in human monocytic cells by Burgermeister, E, Pessara, U, Tibes, U, Küster, A, Heinrich, P C, Scheuer, W V

    Published in European journal of pharmacology (04-02-2000)
    “…Eicosanoids and platelet-activating factor generated upon activation of cytosolic phospholipase A(2) enhance activity of transcription factors and synthesis of…”
    Get full text
    Journal Article
  7. 7

    Suppression of cytokine synthesis, integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A2 by AMANDI-BURGERMEISTER, E, TIBES, U, KAISER, B. M, FRIEBE, W. G, SCHEUER, W. V

    Published in European journal of pharmacology (20-05-1997)
    “…To define the isoform of phospholipases A2 active in inflammation we evaluated the effects of low-molecular-weight inhibitors of secretory and cytosolic…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Suppression of acute experimental inflammation by antisense oligonucleotides targeting secretory phospholipase A2 (sPLA2) in vitro and in vivo experiments by Tibes, U, Röhr, S P, Scheuer, W, Amandi-Burgermeister, E, Litters, A

    “…In HepG2 cells phosphorothioate modified antisense oligonucleotides against a sequence in the Ca2+ binding domain (AS-Ca2+) of type II sPLA2 mRNA restrained…”
    Get more information
    Journal Article
  11. 11
  12. 12